[go: up one dir, main page]

CZ109795A3 - Antimicrobial 5-hydrazine-quionolone derivatives - Google Patents

Antimicrobial 5-hydrazine-quionolone derivatives

Info

Publication number
CZ109795A3
CZ109795A3 CZ951097A CZ109795A CZ109795A3 CZ 109795 A3 CZ109795 A3 CZ 109795A3 CZ 951097 A CZ951097 A CZ 951097A CZ 109795 A CZ109795 A CZ 109795A CZ 109795 A3 CZ109795 A3 CZ 109795A3
Authority
CZ
Czechia
Prior art keywords
quionolone
hydrazine
antimicrobial
derivatives
quionolone derivatives
Prior art date
Application number
CZ951097A
Other languages
Czech (cs)
Other versions
CZ282581B6 (en
Inventor
Thomas Demuth
Ronald White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of CZ109795A3 publication Critical patent/CZ109795A3/en
Publication of CZ282581B6 publication Critical patent/CZ282581B6/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CZ951097A 1992-10-30 1993-10-22 5-hydrazine-choline derivatives and pharmaceutical compositions containing thereof CZ282581B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96896092A 1992-10-30 1992-10-30

Publications (2)

Publication Number Publication Date
CZ109795A3 true CZ109795A3 (en) 1995-12-13
CZ282581B6 CZ282581B6 (en) 1997-08-13

Family

ID=25514997

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ951097A CZ282581B6 (en) 1992-10-30 1993-10-22 5-hydrazine-choline derivatives and pharmaceutical compositions containing thereof

Country Status (21)

Country Link
EP (1) EP0666853A1 (en)
JP (1) JPH08502750A (en)
KR (1) KR950704301A (en)
CN (1) CN1064357C (en)
AU (1) AU687018B2 (en)
BR (1) BR9307347A (en)
CA (1) CA2148003A1 (en)
CZ (1) CZ282581B6 (en)
EG (1) EG20543A (en)
FI (1) FI952049L (en)
HU (1) HUT72072A (en)
IL (1) IL107323A (en)
MX (1) MX9306814A (en)
NO (1) NO951640L (en)
NZ (1) NZ257470A (en)
PL (1) PL178094B1 (en)
RU (1) RU2126000C1 (en)
SG (1) SG59979A1 (en)
SK (1) SK54795A3 (en)
WO (1) WO1994010163A1 (en)
ZA (1) ZA938089B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
EP0775114B1 (en) * 1994-08-02 2000-03-22 The Procter & Gamble Company Process for making antimicrobial compounds
NZ290722A (en) * 1994-08-02 1999-03-29 Procter & Gamble A process for making derivatives of quinolonyl lactam (qla's); intermediates
ES2188890T3 (en) * 1996-02-09 2003-07-01 Toyama Chemical Co Ltd DERIVATIVES OF THE QUINOLEINCARBOXILICO ACID AND ITS SALTS.
RU2248199C1 (en) * 2003-06-02 2005-03-20 Открытое Акционерное Общество "Акционерное Курганское общество медицинских препаратов и изделий "Синтез" (ОАО "Синтез") Eye drops and method for their obtaining
RU2265437C2 (en) * 2003-07-02 2005-12-10 Суханов Александр Владимирович Method for treating gastric and duodenal diseases caused by helicobacter pylori
RU2245134C1 (en) * 2003-09-02 2005-01-27 Открытое акционерное общество "Красфарма" Ofloxacine composition for injections
WO2005026147A1 (en) 2003-09-10 2005-03-24 Kyorin Pharmaceutical Co., Ltd. 7-(4-substituted 3- cyclopropylaminomethyl-1­ pyrrolidinyl) quinolonecarboxylic acid derivative
RS55114B1 (en) * 2005-05-18 2016-12-30 Raptor Pharmaceuticals Inc AEROSOLIZED FLUOROCHINOLONS AND THEIR USE
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CA2528849C (en) 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
EA010601B1 (en) * 2005-06-09 2008-10-30 Янссен Фармацевтика Н.В. Quinoline derivatives as antibacterial agents
CN101020647B (en) * 2007-02-14 2011-03-30 杭州师范学院 A kind of synthetic method of β-cyclopropylaminoacrylic acid (ester)
WO2008115890A2 (en) * 2007-03-19 2008-09-25 Takeda Pharmaceutical Company Limited Mapk/erk kinase inhibitors
CA2701630C (en) * 2007-10-05 2016-10-25 Cylene Pharmaceuticals, Inc. Quinolone analogs and methods related thereto
CN102046603B (en) * 2008-06-03 2014-08-13 埃科特莱茵药品有限公司 [4-(1-Amino-ethyl)-cyclohexyl]-methyl-amine and [6-(1-amino-ethyl)-tetrahydro-pyran-3-yl]-methanol as antibacterial agents base-amine derivatives
PT2346509T (en) 2008-10-07 2020-08-05 Horizon Orphan Llc Inhalation of levofloxacin for reducing lung inflammation
NO2344129T3 (en) 2008-10-07 2018-07-21
AR076222A1 (en) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd DERIVATIVES 2-HYDROXIETIL-1H-QUINOLIN-ONA AND ITS AZAISOTHERAL ANALOGS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR112012004692B8 (en) 2009-09-04 2021-05-25 Mpex Pharmaceuticals Inc solution comprising levofloxacin for use in a method of treating cystic fibrosis in a human.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPH0228178A (en) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd Novel pyridonecarboxylic acid derivative and salt thereof
DE3906365A1 (en) * 1988-07-15 1990-01-18 Bayer Ag 7- (1-PYRROLIDINYL) -3-CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES, METHOD AND SUBSTITUTED (OXA) DIAZABICYCLOOCTANES AND NONANESE AS INTERMEDIATE PRODUCTS, AND ANTIBACTERIAL AGENTS AND FOOD ADDITIVES CONTAINING THEM
HU219403B (en) * 1989-08-16 2001-04-28 Pfizer Inc. Azabicyclo-substituted quinolone and naphthyridone carboxylic acids and process for producing them
EP0525057B1 (en) * 1990-04-18 2000-06-14 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolonyl lactams
AU658384B2 (en) * 1990-11-30 1995-04-13 Warner-Lambert Company Individual stereoisomers of 7-{3-(1-aminoalkyl)-1-pyrrolidinyl}-quinolones and naphthyridones as antibacterial agents

Also Published As

Publication number Publication date
ZA938089B (en) 1994-06-07
SG59979A1 (en) 1999-02-22
CZ282581B6 (en) 1997-08-13
BR9307347A (en) 1999-05-25
FI952049A7 (en) 1995-04-28
NZ257470A (en) 1997-08-22
KR950704301A (en) 1995-11-17
AU5409794A (en) 1994-05-24
NO951640L (en) 1995-06-30
CN1064357C (en) 2001-04-11
MX9306814A (en) 1994-07-29
HUT72072A (en) 1996-03-28
HU9501237D0 (en) 1995-06-28
FI952049A0 (en) 1995-04-28
EG20543A (en) 1999-07-31
NO951640D0 (en) 1995-04-28
IL107323A (en) 2000-06-01
RU2126000C1 (en) 1999-02-10
PL178094B1 (en) 2000-02-29
AU687018B2 (en) 1998-02-19
IL107323A0 (en) 1994-01-25
FI952049L (en) 1995-04-28
CA2148003A1 (en) 1994-05-11
PL308671A1 (en) 1995-08-21
CN1092773A (en) 1994-09-28
WO1994010163A1 (en) 1994-05-11
SK54795A3 (en) 1995-12-06
EP0666853A1 (en) 1995-08-16
JPH08502750A (en) 1996-03-26
RU95110762A (en) 1997-01-10

Similar Documents

Publication Publication Date Title
PL307812A1 (en) Substituted thiazolydinone derivatives
GB9313158D0 (en) Antimicrobial composition
AP9300522A0 (en) Arylprazole fungicides
SG59979A1 (en) Antimicrobial 5-hydrazino-quinolone derivatives
AU1013592A (en) Antibacterial agents
GB9305306D0 (en) Pyrrolo-pyridazione derivatives
HU9301955D0 (en) Benzophenone-hydrazone derivatives
HU9300744D0 (en) 2-oxo-quinoline derivatives
BG98239A (en) Fungicide 2-alkoxy-2-imidazoline-5-one derivatives
ZA932639B (en) Propenoyl-imidazole derivatives
GB2270913B (en) Chlordifluoromethoxyphenyl derivatives
GB2271564B (en) Thioalkylthio carbacephalosporin derivatives
ZA931516B (en) Substituted phenylquinazoline derivatives
EP0565961A3 (en) Ethyl-triazolyl derivatives
HU9301696D0 (en) Pyrimidofuroxane derivatives
GB9223244D0 (en) Phenylpyrazine derivatives
HU9302058D0 (en) Thia-diazinone derivatives
ZA934972B (en) 21-Chloro-pregnane derivative
PL307123A1 (en) Microbicides
HK1013073A (en) Antimicrobial 5-hydrazino-quinolone derivatives
GB9202934D0 (en) Imidazopiperidine derivatives
GB9202355D0 (en) Benzodioxanylimidazoline derivatives
GB9202354D0 (en) Benzodioxanylimidazole derivatives
GB9211409D0 (en) Imidazopiperidine derivatives
ZA932575B (en) Ethyl-triazolyl derivatives

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20011022